Samit Hirawat - EVP,Chief Med.Offr.,Drug Dev. at Bristol Myers Squibb Co

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP,Chief Med.Offr.,Drug Dev.
Stock Symbol
BMY, CELG-RI on NYSE, BMYMP on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Samit Hirawat since 9/17/2023

Holdings reported by Samit Hirawat for Bristol Myers Squibb Co

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, $0.10 par value 60.3K $3.24M $53.79 Mar 10, 2024 Direct
Market Share Units 40.6K $2.19M $53.79 Mar 10, 2024 Direct Common Stock, $0.10 par value
Performance Shares 61K Mar 10, 2024 Direct Common Stock, $0.10 par value
Restricted Stock Units 0 $50.10 Jul 1, 2023 Direct Common Stock, $0.10 par value

Transactions reported by Samit Hirawat for Bristol Myers Squibb Co

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.